U-Neuron Biomedical (6973.TWO) Stock Price
U-Neuron Biomedical Price
Over the last 3 years U-Neuron Biomedical grew revenue by 17.6% annually, reaching 46.21 M TWD. For U-Neuron Biomedical, the net margin of -129.8% is down versus -39.6% a few years ago.
U-Neuron Biomedical stock price
U-Neuron Biomedical business model & stock analysis
Frequently asked questions about U-Neuron Biomedical
Converted at the current exchange rate, the U-Neuron Biomedical share trades at 1.70 EUR (60.50 TWD).
The revenue cannot currently be calculated for U-Neuron Biomedical.
The profit cannot currently be calculated for U-Neuron Biomedical.
The P/E ratio cannot be calculated for U-Neuron Biomedical at the moment.
The P/S cannot be calculated for U-Neuron Biomedical currently.
The Eulerpool Quality Score for U-Neuron Biomedical is 3/10.
The ISIN of U-Neuron Biomedical is TW0006973001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of U-Neuron Biomedical is 6973.TWO. The ticker symbol is used to trade U-Neuron Biomedical shares on the stock exchange.
U-Neuron Biomedical stock
U-Neuron Biomedical Peer Group
U-Neuron Biomedical FIGI
All fundamentals and in-depth analysis of U-Neuron Biomedical
Our stock analysis for U-Neuron Biomedical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of U-Neuron Biomedical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.